Carbapenem resistance: overview of the problem and future perspectives

Therapeutic Advances in Infectious Disease

Volumn 3, Issue 1, 2016, Pages 15-21

  Meletis, Georgios ^a  

^a Labnet Laboratories   (Greece)

Author keywords

antibiotic resistance; carbapenemases; carbapenems

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; DAPTOMYCIN; FOSFOMYCIN; MEROPENEM; METALLO BETA LACTAMASE; PENICILLIN DERIVATIVE; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM;

ANTIBIOTIC RESISTANCE; DRUG INACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVIEW; URINARY TRACT INFECTION;

EID: 85140806063     PISSN: 20499361     EISSN: 2049937X     Source Type: Journal    
DOI: 10.1177/2049936115621709     Document Type: Review

References (62)

1. D.AkajagborS.WilsonK.Shere-WolfeP.DakumM.CharuratB.Gilliam (2013) Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center. Clin Infect Dis57: 1300–1303.
2. R.Ambler (1980) The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci289: 321–331.
3. R.BonomoD.Szabo (2006) Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis43: S49–S56.
4. L.BorgianniF.De LucaM.ThallerY.ChongG.RossoliniJ.Docquier (2015) Biochemical characterization of the POM-1 metallo-β-lactamase from Pseudomonas otitidis. Antimicrob Agents Chemother59: 1755–1758.
5. A.CarrërL.PoirelH.EraksoyA.CagatayS.BadurP.Nordmann (2008) Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother52: 2950–2954.
6. A.CarrërL.PoirelM.YilmazO.AkanC.FerihaG.Cuzon (2010) Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother54: 1369–1373.
7. M.CastanheiraL.DeshpandeD.MathaiJ.BellR.JonesR.Mendes (2011) Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006–2007. Antimicrob Agents Chemother55: 1274–1278.
8. M.CastanheiraM.TolemanR.JonesF.SchmidtT.Walsh (2004) Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase. Antimicrob Agents Chemother48: 4654–4661.
9. CDC (2013) Antibiotic Resistance Threats to the United States. Atlanta, GA: Centers for Disease Control and Prevention. www.cdc.gov/drugresistance/threat-report-2013/index.html (accessed 10 September 2015)
10. G.CuzonT.NaasA.LesenneM.BenhamouP.Nordmann (2010) Plasmid-mediated carbapenem-hydrolysing OXA-48-lactamase in Klebsiella pneumoniae from Tunisia. Int J Antimicrob Agents36: 91–93.
11. L.DortetL.PoirelP.Nordmann (2014) Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int2014: 249856.
12. A.EndimianiA.HujerF.PerezC.BethelK. HujerJ.Kroeger (2009) Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the eastern U. S. A. J Antimicrob Chemother63: 427–437.
13. M.FalagasA.KastorisA.KapaskelisD.Karageorgopoulos (2010) Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis10: 43–50.
14. P.GiakkoupiL.TzouvelekisA.TsakrisV. LoukovaD.SofianouE.Tzelepi (2000) IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob Agents Chemother44: 2247–2253.
15. M.HayD.ThomasJ.CraigheadC.EconomidesJ.Rosenthal (2014) Clinical development success rates for investigational drugs. Nat Biotechnol32: 40–51.
16. I.HenriquesA.MouraA.AlvesM.SaavedraA.Correia (2004) Molecular characterization of a carbapenem-hydrolyzing class A beta-lactamase, SFC-1, from Serratia fonticola UTAD54. Antimicrob Agents Chemother48: 2321–2324.
17. R.HumphriesS.YangP.HemarajataK.WardJ.HindlerS.Miller (2015) First report of ceftazidime-avibactam resistance in a KPC-3 expressing Klebsiella pneumoniae. Antimicrob Agents Chemother59: 6605–6607.
18. B.KitchelD.SundinJ.Patel (2009) Regional dissemination of KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother53: 4511–4513.
19. L.LaurettiM.RiccioA.MazzariolG.CornagliaG.AmicosanteR.Fontana (1999) Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother43: 1584–1590.
20. A.LeavittS.Navon-VeneziaI.ChmelnitskyM.SchwaberY.Carmeli (2007) Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob. Agents Chemother51: 3026–3029.
21. K.LeeJ.YumD.YongH.LeeH.KimJ.Docquier (2005) Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother49: 4485–4491.
22. D.LivermoreM.WarnerD.JamrozyS.MushtaqW.NicholsN.Mustafa (2015) In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase. Antimicrob Agents Chemother59: 5324–5330.
23. G.Meletis (2014) Why should governments invest in antibiotic drug discovery against multi-drug-resistant bacteria?Recent Pat Antiinfect Drug Discov9: 150.
24. G.MeletisD.ChatzidimitriouN.Malisiovas (2015a) Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade. Eur J Clin Microbiol Infect Dis34: 1487–1493.
25. G.MeletisM.ExindariN.VavatsiD.SofianouE.Diza (2012) Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. Hippokratia16: 303–307.
26. G.MeletisE.OustasM.Bagkeri (2014a) Carbapenemase reports from the Balkans: a systematic review. Infez Med22: 85–106.
27. G.MeletisE.OustasC.BotzioriE.KakasiA.Koteli (2015b) Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance. New Microbiol38: 417–421.
28. G.MeletisN.VavatsiM.ExindariE.ProtonotariouE.SianouC.Haitoglou (2014b) Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure. Eur J Clin Microbiol Infect Dis33: 253–258.
29. S.MiyakisA.PefanisA.Tsakris (2011) The challenges of antimicrobial drug resistance in Greece. Clin Infect Dis53: 177–184.
30. O.MoquetC.BouchiatA.KinanaA.SeckO.ArounaR.Bercion (2011) Class D OXA-48 carbapenemase in multidrugresistant enterobacteria, Senegal. Emerg Infect Dis17: 143–144.
31. H.MorrillJ.PogueK.KayeK.LaPlante (2015) Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect Dis2: ofv050.
32. P.NordmannG.CuzonT.Naas (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis9: 228–236.
33. P.NordmannL.PoirelT.WalshD.Livermore (2011) The emerging NDM carbapenemases. Trends Microbiol19: 588–595.
34. G.PeiranoJ.Ahmed-BentleyN.WoodfordJ.Pitout (2011) New Delhi metallo-beta-lactamase from traveler returning to Canada. Emerg Infect Dis17: 242–244.
35. L.PoirelM.CastanheiraA.CarrërC.RodriguezR.JonesJ.Smayevsky (2011) OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother55: 2546–2551.
36. L.PoirelI.Le ThomasT.NaasA.KarimP.Nordmann (2000) Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother44: 622–632.
37. L.PoirelJ.PitoutP.Nordmann (2007) Carbapenemases: molecular diversity and clinical consequences. Future Microbiol2: 501–512.
38. L.PoirelA.PotronP.Nordmann (2012) OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother67: 1597–1606.
39. L.PoirelJ.Rodríguez-MartínezN.Al NaiemiY.Debets-OssenkoppP.Nordmann (2010) Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands. Antimicrob Agents Chemother54: 2420–2424.
40. S.PolliniS.MaradeiP.PecileG.OlivoF. LuzzaroJ.Docquier (2013) FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob Agents Chemother57: 410–416.
41. A.PotronJ.KalpoeL.PoirelP.Nordmann (2011) European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone. Clin Microbiol Infect17: E24–E26.
42. J.QualeS.BratuJ.GuptaD.Landman (2006) Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother50: 1633–1641.
43. A.QueenanK.Bush (2007) Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev20: 440–458.
44. R.RappC.Urban (2012) Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacotherapy32: 399–407.
45. F.Rossi (2011) The challenges of antimicrobial resistance in Brazil. Clin Infect Dis52: 1138–1143.
46. H.SaderD.FarrellR.FlammR.Jones (2014) Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012). Antimicrob Agents Chemother58: 2274–2280.
47. M.Sánchez (2015) Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia. Front Microbiol6: 658.
48. H.Schweizer (2003) Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res2: 48–62.
49. L.TzouvelekisA.MarkogiannakisE.PiperakiM.SouliG.Daikos (2014) Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect20: 862–872.
50. L.TzouvelekisA.MarkogiannakisM.PsichogiouP.TassiosG.Daikos (2012) Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev25: 682–707.
51. M.VillegasK.LolansA.CorreaC.SuarezJ.LopezM.Vallejo (2006) First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother50: 2880–2882.
52. T.Walsh (2010) Emerging carbapenemases: a global perspective. Int J Antimicrob Agents36: S8–S14.
53. T.WalshM.TolemanL.PoirelP.Nordmann (2005) Metallo-beta-lactamases: the quiet before the storm?Clin Microbiol Rev18: 306–325.
54. J.Walther-RasmussenN.Høiby (2007) Class A carbapenemases. J Antimicrob Chemother60: 470–482.
55. J.Walther-RasmussenN.Høiby (2006) OXA-type carbapenemases. J Antimicrob Chemother57: 373–383.
56. M.WatanabeS.IyobeM.InoueS.Mitsuhashi (1991) Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother35: 147–151.
57. H.YigitA.QueenanG.AndersonA.Domenech-SanchezJ.BiddleC.Steward (2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother45: 1151–1161.
58. D.YongM.TolemanJ.BellB.RitchieR.PrattH.Ryley (2012) Genetic and biochemical characterization of an acquired subgroup B3 metallo-β-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia. Antimicrob Agents Chemother56: 6154–6159.
59. D.YongM.TolemanC.GiskeH.ChoK.SundmanK.Lee (2009) Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother53: 5046–5054.
60. E.ZasowskiJ.RybakM.Rybak (2015) The β-lactams strike back: ceftazidime-avibactam. Pharmacotherapy35: 755–770.
61. W.ZhaoZ.Hu (2011a) Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli. Future Microbiol6: 317–333.
62. W.ZhaoZ.Hu (2011b) IMP-type metallo-β-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons. Crit Rev Microbiol37: 214–226.